Aid in Dying Nears One Third of US - Summary - MDSpire

Aid in Dying Nears One Third of US

New laws in New York and Illinois will soon make medical aid in dying available to nearly one-third of Americans.

  • By

  • Paula Span

  • June 8, 2026

  • 8 min

Share

Objective:

To discuss the recent legislative developments regarding medical aid in dying (MAID) in the United States, with a focus on the implications of new laws in populous states like New York and Illinois.

Key Findings:
  • Nearly one-third of Americans will live in states where MAID is legal following new laws in New York and Illinois.
  • Public support for MAID is high, with surveys showing that a majority of respondents do not view it as morally wrong, including specific percentages from recent polls.
  • Legalizing MAID remains contentious, facing opposition from various organizations and requiring stringent eligibility criteria that complicate access.
Interpretation:

The passage of MAID laws in populous states reflects changing societal attitudes towards end-of-life choices, highlighting a growing acceptance despite ongoing opposition and legal challenges.

Limitations:
  • MAID is underutilized, with only 1% or fewer of deaths annually attributed to the law in states where it is legal, raising questions about awareness and accessibility.
  • Eligibility criteria and institutional refusals can limit access to MAID, impacting its perceived effectiveness.
Conclusion:

The trend towards liberalizing MAID laws indicates a growing acceptance of patient autonomy in end-of-life decisions, although practical challenges and opposition remain significant.

Original Source(s)

Aid in Dying Nears One Third of US

  • by Paula Span

  • June 8, 2026

Related Content

Medical Oddities: Prayer for Pain?

This week’s research collection showed that biology, behavior, and environment often intersect in unexpected ways.

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.